Zhao, Jiangnan
Wang, Zijin https://orcid.org/0009-0004-7856-3601
Xiao, Manyu https://orcid.org/0009-0000-0307-0096
Zhang, Yeyuan
Liu, Boxin https://orcid.org/0009-0005-8509-0133
Chen, Silin
Tian, Yiping
Lv, Dongqing
Wang, Pingli
Song, Hai https://orcid.org/0000-0002-7081-9308
Wu, Yuefeng
Liu, Jian https://orcid.org/0000-0002-1447-0973
Wang, Kai https://orcid.org/0000-0003-4328-8799
Funding for this research was provided by:
MOST | National Key Research and Development Program of China (2024YFA1108500)
MOST | National Natural Science Foundation of China (U23A20467)
MOST | National Natural Science Foundation of China (General Grant: 82172899 and 82472637)
MOST | NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Natural Science Foundation of Zhejiang Province (Continuation Grant of Distinguished Young Scholars: RG26H160003)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0502900/ 2023ZD0502902 and 2023ZD0507500/2023ZD0507501)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0529300)
Key R&D Program of Zhejiang (Grant No. 2025C02091)
Medical Scientific Research Foundation of Zhejiang Province, China (Grant No. WKJ-ZJ-2508)
MOST | NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Science Fund for Distinguished Young Scholars of Zhejiang Province (Distinguished Young Scholars: LR22H160002)
Article History
Received: 5 June 2025
Revised: 20 February 2026
Accepted: 9 March 2026
First Online: 30 March 2026
Disclosure and competing interests statement
: K Wang, J Liu, J Zhao, Z Wang, and M Xiao have a patent application for APOBEC3A diagnosis in the positive prediction of IC response.